Financhill
Back

Atara Biotherapeutics Quote, Financials, Valuation and Earnings

Atara Biotherapeutics Price Quote

$8.03
-0.04 (4.83%)
(Updated: September 28, 2024 at 6:19 AM ET)

Atara Biotherapeutics Key Stats

Sell
20
Atara Biotherapeutics (ATRA) is a Sell

Day range:
$7.61 - $8.39
52-week range:
$4.97 - $45.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.66
P/B ratio:
0%

Volume:
106.8K
Avg. volume:
176.3K
1-year change:
-78.75%
Market cap:
$45.8M
Revenue:
$8.6M
EPS:
$-39.35

How Much Does Atara Biotherapeutics Make?

Is Atara Biotherapeutics Growing As A Company?

  • What Is Atara Biotherapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 28.93%
  • What Is Atara Biotherapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Atara Biotherapeutics Stock Price Performance

What Is Atara Biotherapeutics 52-Week High & Low?

Atara Biotherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Atara Biotherapeutics?

Is Atara Biotherapeutics Cash Flow Positive?

  • What Is ATRA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$142M
  • What Is Atara Biotherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $25.1M
  • What Is Atara Biotherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $102.3M

Atara Biotherapeutics Return On Invested Capital

Data Unavailable

Atara Biotherapeutics Earnings Date & Stock Price

Atara Biotherapeutics Competitors

Atara Biotherapeutics Dividend Yield

Atara Biotherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -38.52%
Revenue: 2892.69% -22.79%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 90.50
Upside from Last Price: 1020.74%

Major Shareholders

  • How many ATRA shares are owned by institutional investors?
    7.8M ATRA shares are owned by institutional investors
  • How many ATRA shares are owned by insiders?
    0 ATRA shares are owned by insiders